(1) Each delegator, as defined under *RCW 18.135.020(6), shall maintain a list of specific drugs, diagnostic agents, and vaccines, and the route of administration of each drug, diagnostic agent, and vaccine that the delegatee is authorized to administer under this chapter. Both the delegator and delegatee shall sign the above list, indicating the date of each signature. The signed list shall be forwarded to the secretary of the department of health and shall be available for review.

     (2) Delegatees are prohibited from administering any controlled substance as defined in RCW 69.50.101(d), any experimental drug, and any cancer chemotherapy agent unless a delegator is physically present in the immediate area where the drug is administered.

[2009 c 43 § 5; 2008 c 58 § 3; 1991 c 3 § 276; 1986 c 216 § 4.]

NOTES:

     *Reviser's note: RCW 18.135.020 was alphabetized pursuant to RCW 1.08.015(2)(k), changing subsection (6) to subsection (1).

     Intent -- 2009 c 43: See note following RCW 18.135.010.